Free Trial

Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Janney Montgomery Scott LLC

Teladoc Health logo with Medical background

Janney Montgomery Scott LLC lessened its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 37.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 66,927 shares of the health services provider's stock after selling 39,800 shares during the quarter. Janney Montgomery Scott LLC's holdings in Teladoc Health were worth $608,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in TDOC. Westside Investment Management Inc. increased its position in Teladoc Health by 43.8% during the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider's stock worth $84,000 after purchasing an additional 2,800 shares in the last quarter. Nisa Investment Advisors LLC increased its position in Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after purchasing an additional 424,180 shares in the last quarter. Arkadios Wealth Advisors purchased a new stake in Teladoc Health during the 4th quarter worth about $115,000. Smith Anglin Financial LLC purchased a new stake in Teladoc Health during the 4th quarter worth about $108,000. Finally, Versant Capital Management Inc increased its position in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Oppenheimer dropped their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Bank of America lifted their price target on Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a report on Wednesday. Piper Sandler restated an "overweight" rating and issued a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Finally, Barclays lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $12.08.

Check Out Our Latest Research Report on TDOC

Teladoc Health Trading Down 4.1 %

Shares of NYSE TDOC traded down $0.53 during midday trading on Wednesday, hitting $12.51. The stock had a trading volume of 8,430,817 shares, compared to its average volume of 5,813,556. The company has a fifty day moving average price of $10.13 and a 200 day moving average price of $9.20. The company has a market capitalization of $2.15 billion, a price-to-earnings ratio of -2.17 and a beta of 1.05. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $21.74.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares of the company's stock, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.95% of the stock is currently owned by corporate insiders.

About Teladoc Health

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Articles

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines